Update
$VistaGen Therapeutics(VTGN.US$ Vistagen Announces Positive Results From Phase 2a Pilot Study of Ph15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue. Vistagen Therapeutics Inc: Ph15 Was Safe and Well-Tolerated With an Adverse Event Profile Similar to Placebo
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
多買多賺買少少虧金牛 : How high chance flying?
TrytosaveabitOP 多買多賺買少少虧金牛: Not sure! Gotta see what volume/interest it gets?
多買多賺買少少虧金牛 TrytosaveabitOP: strange movement dropping
TrytosaveabitOP 多買多賺買少少虧金牛: No volume
多買多賺買少少虧金牛 : Is the vol 54mil on 7Aug23 real? Total issue shares only 27mil